ABSTRACT
Surgical treatment for chronic back pain in degenerative lumbar spine has been still complicated. Several kinds of devices for spine fusions have been developed, but they have had both some advantages and disadvantages. Recently, the TFC(Threaded fusion cage) instrument has been introduced in treating lumbar spinal disorders associated with degenerative changes. The authors analysed 15 cases of lumbar degenerative disease treated with adequate decompression and TFC instrumentation between October 1993 and March 1994 at Ewha Womans University Mokdong Hospital. There were 10 females and 5 males. The main surgical indication was serious limitation of daily activity, which was not treated conservatively. The preoperative diagnoses were 6 degenerative stenosis with disc, 6 degenerative spondylolisthesis, 2 spondylosis and spondylolytic spondylolisthests, and 1 FBSS. We observed that 93% of patients(14 of 15) had more than good results and preoperative back pain was markedly reduced. Intervertebral disc space was well restored, and the reduction was possible in spondylolisthesis patients. In our opinion, TFC instrument will be one of good surgical modality in the treatment of degenerative lumbar spine.
Subject(s)
Female , Humans , Male , Back Pain , Constriction, Pathologic , Decompression , Diagnosis , Intervertebral Disc , Spine , Spondylolisthesis , SpondylosisABSTRACT
gamma-Glutamyltransferase(GGT: E.C. 2.3.2.2.) is a glycoprotein enzyme which is involved in glutathione metabolism and amino acid transport through the plasma membrane. It is distributed widely in several organs including liver, kidney, pancrease and brain. GGTs derived from the brain of Wister rats and BALB/c mice were biochemically purified to a specific activity of 4246.2, 862.1 units per mg of protein, a purification folds 93.7, 43.8 and the final yield 65.8, 44.0% respectively. Electrophoretic pattern of purified GGTs from rats and mice brain shows very similar protein fraction each other. We have produced six monoclonal antibodies(GGT-Mab 1-6) against 2-acetamidogluorene treated rat liver GGT. Using these GGT-Mab 1-6 we performed immunohistochemistry(IHC) to study the distribution of GGT isozymes in normal tissues of rat brain and in neoplastic tissues of human brain. The results indicated that human brain GGT was localized in pericytes of blood-brain barrier, especially in the blood-rich portion of the brain(e.g. cerebellum of rat, meningioma and craniopharyngioma of human). Therefore these Maps may be used to evaluate the distribution of GGT isozymes in different tissues.